News Focus
News Focus
Followers 0
Posts 994
Boards Moderated 0
Alias Born 06/03/2015

Re: marzan post# 56814

Tuesday, 08/18/2015 2:39:58 PM

Tuesday, August 18, 2015 2:39:58 PM

Post# of 447409
Yep...agree, Generics will have no chance to file until REDUCE-IT is approved. Some exclusivity will be given for REDUCE-IT unclear what this is. Amarin's not a NME and was never awarded NCE so the FDA leaves this up in the air again for exclusivity round two. So I do think there's an off chance Vascepa gets NCE for REDUCE-IT, because NCE has never been assigned. I think there's a good chance this goes to court,,,again.
BB
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News